Warnex Inc.
TSX : WNX

Warnex Inc.

April 21, 2009 10:34 ET

Warnex to Host Annual Meeting April 28, 2009

LAVAL, QUEBEC--(Marketwire - April 21, 2009) - Warnex Inc. (TSX:WNX) invites all interested parties to attend its Annual Meeting of Shareholders.



Date: Tuesday, April 28, 2009

Time: 11:00 am (EST)

Location: Sheraton Laval, Salon Auteuil-Vimont
2440 Autoroute des Laurentides
Laval, Quebec


In addition to the formal business described in the Management Information Circular, Mark Busgang, President and CEO of Warnex, will present an update on corporate activities.

About Warnex

Warnex (www.warnex.ca) is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare sectors. Warnex's analytical services division provides pharmaceutical and biotechnology companies with a variety of quality control services, including traditional chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex's bioanalytical services division specializes in bioequivalence and bioavailability studies for clinical trials. Warnex's medical laboratories division focuses on genetic and biochemical testing for the healthcare industry and has extensive expertise in genetic testing for human identification, molecular diagnostics, and pharmacogenetics.

Contact Information